Recent breakthroughs in artificial intelligence and genomic technologies are revolutionizing protein research and production. New methods like ProTrek integrate multimodal protein language models to enhance protein analysis. DeepSeq.AI is collaborating with researchers to develop AI models that predict manufacturability of protein-based drugs expressed in CHO cells, addressing manufacturing bottlenecks. Meanwhile, innovative assays and software platforms, such as Illumina Protein Prep and Giotto Suite, are enabling scalable, high-sensitivity plasma proteome screening and spatial multiomics data analysis. These advances collectively promise to accelerate drug discovery and biopharmaceutical manufacturing through improved protein characterization and prediction tools.